Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

YM-53601

SKU: orb1701462

Description

YM-53601 is a potent inhibitor of squalene synthase (FDFT1), functioning as a cholesterol-lowering agent in rodent models. It demonstrates research utility in studies of lipid metabolism, adipogenesis, and has shown potential antiviral and chemosensitizing effects in hepatocellular carcinoma research in vivo.

Research Area

Epigenetics & Chromatin, Infectious Disease & Virology, Metabolism Research, Protein Biochemistry, Signal Transduction

Images & Validation

Key Properties

CAS Number182959-33-7
MW372.86
Purity99.65% (May vary between batches)
FormulaC21H22ClFN2O
SMILESO(C/C(/F)=C\1/C2CCN(C1)CC2)C=3C=C4C(C=5C(N4)=CC=CC5)=CC3.Cl
TargetPKC,HCV Protease,Transferase
SolubilityDMSO:80 mg/mL (214.56 mM);10% DMSO+40% PEG300+5% Tween-80+45% Saline:3.3 mg/mL (8.85 mM)

Bioactivity

Target IC50
HepG2 cells (rat liver microsomes):90 nM|HepG2 cells (human liver microsomes):79 nM|HepG2 cells (hamster liver microsomes):170 nM|Squalene synthase (hamster liver):170 nM|HepG2 cells (rhesus monkey liver microsomes):45 nM|HepG2 cells (guinea pig liver microsomes):46 nM
In Vivo
YM-53601 inhibited cholesterol biosynthesis in rats at an ED50 of 32 mg/kg . In addition, in a hamster model, YM-53601 reduced plasma non-HDL cholesterol levels by approximately 70% when administered orally at 50 mg/kg/day for 5 days. YM-53601 also enhanced doxorubicin-mediated inhibition of hepatocellular carcinoma (HCC) cell proliferation and cell death in vivo.
In Vitro
YM-53601 inhibited squalene synthase activity in a variety of animal and human cell lines, with IC50s of 90, 170, 46, 45, and 79 nM in liver microsomes of rat, hamster, guinea pig, rhesus monkey, and human HepG2 cells, respectively. YM-53601 inhibited the conversion of [3H] farnesyl diphosphate to [3H] squalene by squalene synthase in hamster liver with an IC50 of 170 nM. In H35 cells, 1 μM M-53601 enhanced sensitivity to toxic carotenoids, lonidamine and adriamycin, and reduced mitochondrial cholesterol levels in H35 and HepG2 cells.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

YM 53601, YM53601, YM-53601

Similar Products

  • YM-53601 free base [orb1708197]

    182959-28-0

    336.4

    C21H21FN2O

    50 mg, 100 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 210.00
5 mg
$ 460.00
1 ml x 10 mM (in DMSO)
$ 500.00
10 mg
$ 710.00
25 mg
$ 1,360.00
50 mg
$ 2,190.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry